Testosterone gel and method of use
DCFirst Claim
Patent Images
1. A gel pharmaceutical composition consisting of:
- a) 1.62% (w/w) testosterone;
b) 1.0% (w/w) isopropyl myristate;
c) 68.1% (w/w) absolute ethanol; and
d) 1.0% (w/w) of a gelling agent, which gelling agent is an anionic polymer that has been neutralized with an amount of neutralizer sufficient to form a gel; and
e) water.
3 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.
-
Citations
8 Claims
-
1. A gel pharmaceutical composition consisting of:
-
a) 1.62% (w/w) testosterone; b) 1.0% (w/w) isopropyl myristate; c) 68.1% (w/w) absolute ethanol; and d) 1.0% (w/w) of a gelling agent, which gelling agent is an anionic polymer that has been neutralized with an amount of neutralizer sufficient to form a gel; and e) water. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
Specification